pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

499 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: patent expiry×type: pdufa×type: earnings×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease10
    • Dermatology2
    • Oncology2
    • Pulmonology1

    Week of Apr 20, 2026

    6
    ›Apr 23, 2026earnings91d agoACME UNITED CORP earningsACME UNITED CORP

    Anticipated earnings call for ACME UNITED CORP ($ACU).

    full page →yahoo earnings ↗
    ›Apr 23, 2026earnings91d agoSanofi earningsSanofi

    Anticipated earnings call for Sanofi ($SNY).

    full page →yahoo earnings ↗
    ›Apr 24, 2026patent expiry90d agoDaiichi Sankyo Co Ltd — laninamivir (Constraining Patent Expiry (Japan))laninamivir

    Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections

    full page →laninamivir →source: globaldata
    ›Apr 24, 2026patent expiry90d agoEisai Co Ltd — lenvatinib mesylate (Constraining Patent Expiry (US))lenvatinib mesylate

    Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S

    full page →lenvatinib mesylate →source: globaldata
    ›Apr 25, 2026patent expiry89d agoStemline Therapeutics Inc — SL-901 (Constraining Patent Expiry (Japan))SL-901

    Therapy area: Oncology, Undisclosed. Indication: Lung Cancer, Solid Tumor, Unspecified Rare Disease

    full page →SL-901 →source: globaldata
    ›Apr 26, 2026patent expiry88d agoBlue Blood Biotech Corp — BB-101 (Constraining Patent Expiry (Japan))BB-101

    Therapy area: Dermatology. Indication: Diabetic Foot Ulcers

    full page →BB-101 →source: globaldata

    Week of Apr 27, 2026

    44
    ›Apr 27, 2026patent expiry87d agoBill & Melinda Gates Medical Research Institute — SB-692342 (Constraining Patent Expiry (Japan))SB-692342

    Therapy area: Infectious Disease. Indication: Pulmonary Tuberculosis

    full page →SB-692342 →source: globaldata
    ›Apr 27, 2026pdufa
    ← prev
    page 1 of 10
    next →
    87d ago
    Regeneron Pharmaceuticals Inc — dupilumab (PDUFA)dupilumab

    Therapy area: Dermatology. Indication: Chronic Urticaria

    full page →dupilumab →source: globaldata
    ›Apr 28, 2026patent expiry86d agoGSK plc — dolutegravir sodium ODT (Constraining Patent Expiry (Japan))dolutegravir sodium

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →dolutegravir sodium →source: globaldata
    ›Apr 28, 2026patent expiry86d agoGSK plc — (abacavir sulfate + dolutegravir sodium+ lamivudine) ODT (Constraining Patent Expiry (Japan))(abacavir sulfate + dolutegravir sodium + lamivudine)

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →(abacavir sulfate + dolutegravir sodium + lamivudine) →source: globaldata
    ›Apr 28, 2026patent expiry86d agoGSK plc — cabotegravir sodium (Constraining Patent Expiry (US))cabotegravir sodium

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →cabotegravir sodium →source: globaldata
    ›Apr 28, 2026patent expiry86d agoViiV Healthcare UK Ltd — cabotegravir + rilpivirine LA (Constraining Patent Expiry (US))cabotegravir + rilpivirine LA

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →cabotegravir + rilpivirine LA →source: globaldata
    ›Apr 28, 2026patent expiry86d agoViiV Healthcare UK Ltd — cabotegravir LA (Constraining Patent Expiry (US))cabotegravir LA

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →cabotegravir LA →source: globaldata
    ›Apr 28, 2026pdufa86d agoMerck & Co Inc — (doravirine + islatravir hydrate) (PDUFA)(doravirine + islatravir hydrate)

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →(doravirine + islatravir hydrate) →source: globaldata
    ›Apr 28, 2026earnings86d agoNOVARTIS AG earningsNOVARTIS AG

    Anticipated earnings call for NOVARTIS AG ($NVS).

    full page →yahoo earnings ↗
    ›Apr 28, 2026earnings86d agoINCYTE CORP earningsINCYTE CORP

    Anticipated earnings call for INCYTE CORP ($INCY).

    full page →yahoo earnings ↗
    ›Apr 28, 2026earnings86d agoECOLAB INC. earningsECOLAB INC.

    Anticipated earnings call for ECOLAB INC. ($ECL).

    full page →yahoo earnings ↗
    ›Apr 28, 2026earnings86d agoOrion Group Holdings Inc earningsOrion Group Holdings Inc

    Anticipated earnings call for Orion Group Holdings Inc ($ORN).

    full page →yahoo earnings ↗
    ›Apr 29, 2026pdufa85d agoSanofi — teplizumab (PDUFA)teplizumab

    Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)

    full page →teplizumab →source: globaldata
    ›Apr 29, 2026earnings85d agoAbbVie Inc. earningsAbbVie Inc.

    Anticipated earnings call for AbbVie Inc. ($ABBV).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings85d agoASTRAZENECA PLC earningsASTRAZENECA PLC

    Anticipated earnings call for ASTRAZENECA PLC ($AZN).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings85d agoGSK plc earningsGSK plc

    Anticipated earnings call for GSK plc ($GSK).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings85d agoREGENERON PHARMACEUTICALS, INC. earningsREGENERON PHARMACEUTICALS, INC.

    Anticipated earnings call for REGENERON PHARMACEUTICALS, INC. ($REGN).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings85d agoTEVA PHARMACEUTICAL INDUSTRIES LTD earningsTEVA PHARMACEUTICAL INDUSTRIES LTD

    Anticipated earnings call for TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings85d agoGLAUKOS Corp earningsGLAUKOS Corp

    Anticipated earnings call for GLAUKOS Corp ($GKOS).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings85d agoBIOGEN INC. earningsBIOGEN INC.

    Anticipated earnings call for BIOGEN INC. ($BIIB).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings85d agoBausch & Lomb Corp earningsBausch & Lomb Corp

    Anticipated earnings call for Bausch & Lomb Corp ($BLCO).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings85d agoSBA COMMUNICATIONS CORP earningsSBA COMMUNICATIONS CORP

    Anticipated earnings call for SBA COMMUNICATIONS CORP ($SBAC).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings85d agoAGIOS PHARMACEUTICALS, INC. earningsAGIOS PHARMACEUTICALS, INC.

    Anticipated earnings call for AGIOS PHARMACEUTICALS, INC. ($AGIO).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings85d agoIONIS PHARMACEUTICALS INC earningsIONIS PHARMACEUTICALS INC

    Anticipated earnings call for IONIS PHARMACEUTICALS INC ($IONS).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings85d agoAvantor, Inc. earningsAvantor, Inc.

    Anticipated earnings call for Avantor, Inc. ($AVTR).

    full page →yahoo earnings ↗
    ›Apr 30, 2026patent expiry84d agoBasilea Pharmaceutica Ltd — isavuconazonium sulfate (Constraining Patent Expiry (US))isavuconazonium sulfate

    Therapy area: Infectious Disease. Indication: Aspergillosis, Candidiasis, Cryptococcal Meningitis, Cryptococcosis, Zygomycosis (Mucormycosis)

    full page →isavuconazonium sulfate →source: globaldata
    ›Apr 30, 2026pdufa84d agoAxsome Therapeutics Inc — (bupropion hydrochloride + dextromethorphan) ER (PDUFA)(bupropion hydrochloride + dextromethorphan) ER

    Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease

    full page →(bupropion hydrochloride + dextromethorphan) ER →source: globaldata
    ›Apr 30, 2026earnings84d agoMERIT MEDICAL SYSTEMS INC earningsMERIT MEDICAL SYSTEMS INC

    Anticipated earnings call for MERIT MEDICAL SYSTEMS INC ($MMSI).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoMerck & Co., Inc. earningsMerck & Co., Inc.

    Anticipated earnings call for Merck & Co., Inc. ($MRK).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoCARDINAL HEALTH INC earningsCARDINAL HEALTH INC

    Anticipated earnings call for CARDINAL HEALTH INC ($CAH).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoDEXCOM INC earningsDEXCOM INC

    Anticipated earnings call for DEXCOM INC ($DXCM).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoELI LILLY & Co earningsELI LILLY & Co

    Anticipated earnings call for ELI LILLY & Co ($LLY).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoSTRYKER CORP earningsSTRYKER CORP

    Anticipated earnings call for STRYKER CORP ($SYK).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoBRISTOL MYERS SQUIBB CO earningsBRISTOL MYERS SQUIBB CO

    Anticipated earnings call for BRISTOL MYERS SQUIBB CO ($BMY).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoAMGEN INC earningsAMGEN INC

    Anticipated earnings call for AMGEN INC ($AMGN).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoBIOMARIN PHARMACEUTICAL INC earningsBIOMARIN PHARMACEUTICAL INC

    Anticipated earnings call for BIOMARIN PHARMACEUTICAL INC ($BMRN).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoBAXTER INTERNATIONAL INC earningsBAXTER INTERNATIONAL INC

    Anticipated earnings call for BAXTER INTERNATIONAL INC ($BAX).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoCORCEPT THERAPEUTICS INC earningsCORCEPT THERAPEUTICS INC

    Anticipated earnings call for CORCEPT THERAPEUTICS INC ($CORT).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoTravere Therapeutics, Inc. earningsTravere Therapeutics, Inc.

    Anticipated earnings call for Travere Therapeutics, Inc. ($TVTX).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoARVINAS, INC. earningsARVINAS, INC.

    Anticipated earnings call for ARVINAS, INC. ($ARVN).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoALNYLAM PHARMACEUTICALS, INC. earningsALNYLAM PHARMACEUTICALS, INC.

    Anticipated earnings call for ALNYLAM PHARMACEUTICALS, INC. ($ALNY).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoSummit Therapeutics Inc. earningsSummit Therapeutics Inc.

    Anticipated earnings call for Summit Therapeutics Inc. ($SMMT).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoILLUMINA, INC. earningsILLUMINA, INC.

    Anticipated earnings call for ILLUMINA, INC. ($ILMN).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings84d agoTENET HEALTHCARE CORP earningsTENET HEALTHCARE CORP

    Anticipated earnings call for TENET HEALTHCARE CORP ($THC).

    full page →yahoo earnings ↗
    $ACU46.28-1.53%
    $SNY44.12+0.85%
    $NVS153.87+2.88%
    $GSK50.78+1.48%
    $REGN672.45-0.41%
    $GSK50.78+1.48%
    $GSK50.78+1.48%
    $MRK126.26+1.50%
    $INCY117.39+1.50%
    $ECL265.87+0.63%
    $ORN13.11-2.09%
    $SNY44.12+0.85%
    $ABBV256.10+1.07%
    $AZN169.34+2.93%
    $GSK50.78+1.48%
    $GKOS153.09-1.52%
    $BIIB203.16+1.61%
    $REGN672.45-0.41%
    $TEVA31.16-0.61%
    $BLCO15.99+0.06%
    $SBAC178.80+1.12%
    $IONS53.39+0.83%
    $AGIO37.36-6.74%
    $AXSM236.95+6.91%
    $AVTR10.99+3.10%
    $MMSI73.48-2.25%
    $MRK126.26+1.50%
    $CAH229.35+1.00%
    $DXCM74.75-1.24%
    $BMY61.34+0.67%
    $LLY1175.41+2.49%
    $SYK314.58-1.43%
    $AMGN369.17+0.80%
    $CORT95.65+4.46%
    $BAX22.21+0.63%
    $BMRN59.21+0.17%
    $TVTX55.62-1.71%
    $ALNY271.37-0.48%
    $ARVN8.2600+2.99%
    $SMMT15.12+3.32%
    $ILMN192.35-0.09%
    $THC196.49+1.09%